Global Diabetes Injection Pens Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Diabetes Injection Pens Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Diabetes Injection Pens also called insulin pens are used by people with diabetes to inject insulin. The pens include an insulin cartridge, a dial to measure dosage.
Diabetes Injection Pens report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Diabetes Injection Pens market is projected to reach US$ 6487.4 million in 2034, increasing from US$ 4284 million in 2022, with the CAGR of 6.0% during the period of 2024 to 2034. Demand from Hospital & Clinic and Retail Pharmacy are the major drivers for the industry.
Global diabetes injection pens key players include Novo Nordisk, Eli Lilly, Sanofi, BD, etc. Global top 1 manufacturer hold a share nearly 50%.
Europe is the largest market, with a share over 45%, followed by China and North America, both have a share about 35 percent.
In terms of product, reusable insulin pens is the largest segment, with a share over 80%. And in terms of application, the largest application is retail pharmacy, followed by hospital and clinic, online sales, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Diabetes Injection Pens market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Novo Nordisk
Eli Lilly
Sanofi
BD
Ypsomed Holding
Dongbao
Owen Mumford
Ganlee
Delfu
Segment by Type
Reusable Insulin Pens
Disposable Insulin Pens
Hospital & Clinic
Retail Pharmacy
Online Sales
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Diabetes Injection Pens market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Diabetes Injection Pens, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Diabetes Injection Pens industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Diabetes Injection Pens in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Diabetes Injection Pens introduction, etc. Diabetes Injection Pens Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Diabetes Injection Pens market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Diabetes Injection Pens report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Diabetes Injection Pens market is projected to reach US$ 6487.4 million in 2034, increasing from US$ 4284 million in 2022, with the CAGR of 6.0% during the period of 2024 to 2034. Demand from Hospital & Clinic and Retail Pharmacy are the major drivers for the industry.
Global diabetes injection pens key players include Novo Nordisk, Eli Lilly, Sanofi, BD, etc. Global top 1 manufacturer hold a share nearly 50%.
Europe is the largest market, with a share over 45%, followed by China and North America, both have a share about 35 percent.
In terms of product, reusable insulin pens is the largest segment, with a share over 80%. And in terms of application, the largest application is retail pharmacy, followed by hospital and clinic, online sales, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Diabetes Injection Pens market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Novo Nordisk
Eli Lilly
Sanofi
BD
Ypsomed Holding
Dongbao
Owen Mumford
Ganlee
Delfu
Segment by Type
Reusable Insulin Pens
Disposable Insulin Pens
Segment by Application
Hospital & Clinic
Retail Pharmacy
Online Sales
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Diabetes Injection Pens market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Diabetes Injection Pens, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Diabetes Injection Pens industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Diabetes Injection Pens in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Diabetes Injection Pens introduction, etc. Diabetes Injection Pens Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Diabetes Injection Pens market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices